Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain 26 pseudogene 2 (ANKRD26P2) is a processed pseudogene located on chromosome 13q13.3. It is related in sequence to ankyrin repeat domain-containing protein genes but does not encode a functional protein. There are no known associated biological functions, disease roles, or interactions with drugs for ANKRD26P2. It is primarily referenced in genomic databases as a non-functional remnant of gene duplication or retrotransposition, common among processed pseudogenes in the human genome. If you are seeking therapeutic targets, ANKRD26P2 should be excluded as it does not code for a protein or functional RNA and is not a receptor, enzyme, or acknowledged disease driver.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 26 pseudogene 2 (ANKRD26P2).